Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07216742 · ClinicalTrials.gov registry record · Phase 3

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

A Phase 3 study of Infertility (IVF Patients), sponsored by Granata Bio Corporation.

Recruiting
Registry status
Phase 3
Development phase
659
Enrollment target
16
Study locations

NCT07216742 is a Phase 3 study of Infertility (IVF Patients) that is actively recruiting participants, run by Granata Bio Corporation. The registered enrollment target is 659 participants, above the 406-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (62% higher). The trial reports 16 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07216742, a Phase 3 study of Infertility (IVF Patients), is actively recruiting participants, sponsored by Granata Bio Corporation.

RECRUITING
Registry status
Phase 3
Development phase
659 participants
Enrollment target
16
Study locations

Study Summary

The goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reproductive Technology (ART) cycle in in women with a diagnosis of infertility.

Conditions Studied

Infertility (IVF Patients)

Interventions

  • DRUG Placebo
  • DRUG hMG subcutaneous injection

Study Locations (16)

Florida

  • IVF Florida Reproductive Associates - Margate
  • Center for Reproductive Medicine - Winter Park

North Carolina

  • Reach Fertility - Charlotte
  • Carolina Conceptions - Raleigh

Texas

  • CARE Fertility - Bedford
  • Shady Grove Houston - Webster

California

  • HRC Fertility - Encino

Connecticut

  • Illume Fertility - Norwalk

Delaware

  • Reproductive Associates of Delaware CCRM - Newark

Georgia

  • Reproductive Biology Associates (RBA) - Atlanta

Hawaii

  • Fertility Institute of Hawaii - Honolulu

Trial Details

FieldValue
Enrollment Target 659 participants
Start Date 2025-11-01
Est. Completion 2028-11
Phase Phase 3

Sponsor

Granata Bio Corporation

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07216742

The ClinicalTrials.gov registry entry for NCT07216742 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 659 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 406-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (62% higher). The listed sponsor is Granata Bio Corporation, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility (IVF Patients) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07216742 reports 16 study locations spanning 13 distinct geographic areas - top geographies include Florida, North Carolina, Texas.

Frequently Asked Questions

What is clinical trial NCT07216742 about?

NCT07216742 is a clinical study titled "Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.". The goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reproductive Technology (A...

What is the current status of trial NCT07216742?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 659 participants. The study started on 2025-11-01. Estimated completion is 2028-11.

What conditions does trial NCT07216742 study?

This clinical trial studies the following conditions: Infertility (IVF Patients).

What interventions are being tested in trial NCT07216742?

The interventions under investigation include: Placebo (DRUG), hMG subcutaneous injection (DRUG).

Who is sponsoring clinical trial NCT07216742?

This trial is sponsored by Granata Bio Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07216742 being conducted?

This trial has 16 study locations across California, Connecticut, Delaware, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Infertility (IVF Patients)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Infertility (IVF Patients)

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.